An Open-label, Placebo-controlled Phase 1 Study to Evaluate the Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 27 Apr 2012
At a glance
- Drugs Linezolid (Primary)
- Indications Bacterial infections
- Focus Pharmacodynamics
- Sponsors Pfizer
- 27 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 13 Mar 2012 New trial record